UCSF, Osiris start cardiac stem cell study
Researchers at UCSF Medical Center started enrolling patients in an early-stage adult stem cell therapy, developed by Osiris Therapeutics Inc. , for first-time heart attack patients. The two-year Phase II trial — the first stem cell clinical trial …
[Read the full article here]Related News:
Cardiac stem cell trial seeks to treat some heart attack patients
Stem cell trial seeks to treat heart attack patients
Stem cell therapy aims to prevent permanent damage from heart attacks